Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2025 / June / Cracking the Code of Phages to Fight TB
Microscopy Translational Science News and Research

Cracking the Code of Phages to Fight TB

How new structural insights captured in high-resolution images could fuel next-gen therapies for TB

By Rob Coker 06/18/2025 2 min read

Share

0625-109-Cracking-the-Code-of-Phages-to-Fight-TB_Teaser.png

Credit: Scripps Research

Scientists at Scripps Research and the University of Pittsburgh have captured the first high-resolution structural images of a virus that infects mycobacteria, the bacterial genus responsible for TB. They hope their work could pave the way for phage-based therapies targeting drug-resistant strains of TB.​

TB remains one of the world's deadliest infectious diseases, claiming over a million lives annually. The rise of antibiotic-resistant mycobacteria has intensified the urgency for alternative treatments. Phage therapy, which utilizes viruses known as bacteriophages to infect and kill specific bacteria, is being explored as a new solution. However, the structural mechanisms by which mycobacteriophages infect their hosts have been poorly understood until now.​

In their study, the team used imaging techniques, including single-particle cryo-electron microscopy (cryo-EM) and cryo-electron tomography (cryo-ET), to visualize the mycobacteriophage Bxb1 at near-atomic resolution during various stages of infection. The images revealed how Bxb1 attaches to mycobacteria, injects its genetic material, and initiates infection.​

Contrary to expectations, Bxb1 does not form a channel through the bacterial membrane to deliver its DNA, suggesting a unique genome translocation mechanism distinct from other known phages. Additionally, the study revealed significant structural changes in the phage's tail tip upon binding to the bacterial surface, indicating a dynamic infection process.​

Understanding these mechanisms is crucial, given the complex and robust cell walls of mycobacteria, which present a formidable barrier to infection. By elucidating how Bxb1 overcomes these defenses, researchers can better comprehend phage-host interactions and identify key structural elements essential for effective infection.

The study’s findings also have practical implications for developing phage therapies against antibiotic-resistant TB. By characterizing the structures of various mycobacteriophages, scientists can identify the most effective candidates for therapeutic applications.​

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Rob Coker

Following a Bachelor’s degree in English Literature and a Master’s in Creative Writing, I entered the world of publishing as a proofreader, working my way up to editor. The career so far has taken me to some amazing places, and I’m excited to see where I can go with Texere and The Medicine Maker.

More Articles by Rob Coker

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #3
Microscopy
The Analytical Scientist Innovation Awards 2024: #3

December 6, 2024

4 min read

Bruker’s multiphoton microscopy module, OptoVolt, ranks third in our Innovation Awards. Here, Jimmy Fong, product development lead, walks us through the major moments during development.

Let Me See That Brain
Microscopy
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

Loading the Molecular Dice
Microscopy
Loading the Molecular Dice

December 12, 2024

2 min read

How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research

Found in Translation
Microscopy
Found in Translation

December 16, 2024

1 min read

Cryo-EM addresses a key question in gene expression: how ribosomes initiate translation

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.